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Background: Results of the studies about association between serum selenium concentration and ges-
tational hyperglycemia are inconsistent. Some studies have demonstrated that women with gestational
diabetesmellitus (GDM)have lowerSeconcentrationswhile contrary results are reported inother studies.
Aim: The aim of this study is to compare the serum Se concentration in women with GDM and normo-
glycemic pregnant women via a systematic review and meta-analysis.
Methods:A computerized literature search on four databases (PubMed, Cochrane register of control trials,
Scopus and Google scholar) was performed from inception through August 2013. Necessary data were
extracted and random effects model was used to conduct the meta-analysis.
Results: Six observational studies (containing 147 women with GDM and 360 normoglycemic pregnant
women) were found, which had compared serum Se concentration in women suffering from GDM with
normal pregnant ones.Ourmeta-analysis revealed that serumSe concentrationwas lower inwomenwith
GDM compared to normoglycemic pregnant women (Hedges =−1.34; 95% CI: −2.33 to −0.36; P<0.01).
Stratiﬁedmeta-analysis demonstrated that concentrationof Se in the sera ofwomenwithGDMwas lower
than normal pregnant women both in second and third trimesters, but the result was not signiﬁcant
in second trimester (second trimester: Hedges =−0.68; 95% CI: −1.60−0.25; P=0.15, third trimester:
Hedges =−2.81; 95% CI: −5.21 to −0.42; P<0.05). It was also demonstrated that serum Se status was
lower in pregnant women with impaired glucose tolerance (IGT) compared to normoglycemic pregnant
women (Hedges =−0.85; 95% CI: −1.18 to −0.52).
Conclusion: The available evidences suggest that serumSe concentration is signiﬁcantly lower in pregnant
women with gestational hyperglycemia compared to normal pregnant women.ntroduction
Gestational diabetesmellitus (GDM)as a temporary formof type
diabetes mellitus (T2DM) is one of the most prevalent compli-
ations in pregnancy [1]. GDM has become more common due to
ncremental prevalence of obesity and T2DM. Its prevalence varies
rom1.7% to 11.7% around theworld [2]. During normal pregnancy,
nsulin resistance increases in parallel with increasing in oxida-
ive stress which leads to reduction in antioxidant levels [3]. These
∗ Corresponding author at: Department of Community Nutrition, School of Nutri-
ion and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran.
el.: +98 311 7922776; fax: +98 311 7922776.
E-mail address: tinajafari15@yahoo.com (T. Jafari).
ttp://dx.doi.org/10.1016/j.jtemb.2014.09.006
946-672X/© 2014 Elsevier GmbH. All rights reserved.© 2014 Elsevier GmbH. All rights reserved.
conditions are more prominent in women with GDM; in whom
glucose oxidation, protein glycation, and lipid peroxidation lead
to free radicals accumulation [1]. It seems that a positive correla-
tion exists between erythrocyte glutathione peroxidase-1 (GPX1)
activity and insulin resistance. This can be explained through the
fact that oxidative stress reduces insulin secretion and increases
insulin resistance; therefore, it is linked toT2DM [3].
Selenium (Se) as an essential trace element has an important
role in the action of antioxidants such as glutathione peroxidases
(GPxs) [4]. Also, it is proposed that Se has anti-diabetic functions
due to its insulin-like characteristics; hence Se supplementation
seems to have beneﬁcial effects in diabetic patients [5,6]. It seems
that the relationship between low Se concentration and impaired
glucose tolerance is exclusive to pregnancy, because some evi-
dences show that serum Se concentration is higher in patientswith
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Total references found via search in 
several databases:  1092 records 
Excluded by titles and 
abstracts:  988 records 
- Irrelevant topics: 
620 records 
- Studies on animal 
models: 386 
records 
Arcles reviewed and assessed through 
full texts: 104 records 
Excluded due to lack of data 
on serum Se concentraon 
in pregnancy: 97 records  
Arcles included in systemac review: 7 
records
Excluded due to lack of 
control group: 1 record 
Arcles included in meta-analysis: 6 
records
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2DM [7,8]. Stranges et al. also suggested that Se supplementation
ay increase the risk of T2DM [9]. In a recently published meta-
nalysis evaluating the effects of Se supplementation on risk of
2DM and cardiovascular disease, the authors concluded that Se
upplementation cannot signiﬁcantly increase the risk of T2DM
10].
The results of the studies about association between selenium
tatus and GDM or gestational hyperglycemia are inconsistent.
ome studies have shown that women with GDM have lower con-
entrations of serum Se compared to healthy pregnant women
11–14]; however, a study performed byMolnar et al. [15] showed
hat serumSeconcentration is signiﬁcantlyhigher inGDMpatients;
hile Al-Saleh et al. [16] did not ﬁnd a signiﬁcant association
etween serum Se concentration and GDM.
Referring to the scientiﬁc literature, no review article has been
ublished on the association between selenium status and GDM.
n the present study, we conducted a meta-analysis on the subject
o quantify the association between maternal selenium status and
DM.
aterials and methods
Thestudyprotocolwas registered inPROSPERO, an international
atabase of prospectively registered systematic reviews in health
nd social care, with the registration number: CRD42013005038.
e followed the Preferred Reporting Items for Systematic Reviews
nd Meta-Analyses (PRISMA) criteria to conduct and report the
esults of the present study.ntiﬁcation, inclusion and exclusion.
Search strategy
Acomputerized literature search on four databases, i.e., PubMed
(http://www.ncbi.nlm.nih.gov/pubmed), Cochrane register of con-
trol trials (http://onlinelibrary.wiley.com/cochranelibrary/search),
Scopus (http://www.scopus.com/home.url) and Google scholar
(http://scholar.google.com)wasperformed from inception through
August 2013. We used keywords selected from Medical Sub-
ject Headings (MeSH; http://www.ncbi.nlm.nih.gov/mesh) or
other keywords including “Selenium”[Mesh], “Selenium Com-
pounds”, “Selenium-Binding Proteins”, “selenium*” and “selenate”
in combination with “Diabetes, Gestational”, “gestational dia-
betes mellitus”, “pregnancy”, and “gestation”. Two authors
evaluated the studies separately through the review of the
titles, abstracts, and if necessary, full texts (TJ and AAF).
References of related papers were more extensively read by
authors to avoid missing articles. Any disagreements in select-
ing related papers were resolved by debate with a third author
(ASA).
Inclusion criteria
Observational studies performed in adult women to assess
serum Se levels at any time of gestational period in both pregnant
women with gestational hyperglycemia or GDM and healthy
pregnantwomenas their control groupwereenrolled in the current
systematic review and meta-analysis.
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Table 1
Characteristics of studies enrolled in meta-analysis.
Study/Year
(Design)
Ref. Noa GDMb (n) IGTc (n) NPWd (n) Gestational age (week) Serum Se concentration (g/L)
GDM NPW GDM IGT NPW
Tan et al., 2001
(Case control)
11 57 98 40 20–33 20–33 66.0 ± 12.0 63.1 ± 13.2 78.5 ± 17.7
83 – 50 33–42 33–42 61.5 ± 13.1 – 70.7 ± 15.2
Al-Saleh et al. 2004
(Case control)
12 15 – 15 39±0.3 40±0.4 75.2 ± 3.1 – 102.3 ± 3.1
Bo et al. 2005
(Case control)
13 29 42 123 24–30 24–30 8.8 ± 1.3* 9.7 ± 1.4* 10.8 ± 1.8*
Al-Saleh et al. 2007
(Case control)
16 10 – 11 38±0.4 40±0.5 85.1 ± 5.4 – 89 ± 4.9
Kilinc et al. 2008
(Cross sectional)
14 30 49 101 24–28 24–28 34.7 ± 8.7 39.9 ± 6.5 50.7 ± 9.8
Molnar et al. 2008
(Case control)
15 17 – 20 24–28 24–28 51.7 ± 11.6 – 40.5 ± 8.0
* mol/L.
a Reference number.
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Ib Gestational diabetes mellitus.
c Impaired glucose tolerance.
d Normal pregnant women.
xclusion criteria
Studies compared normal pregnant women with diabetic or
yperglycemic pregnant women (meaning that they were diabetic
r hyperglycemic before pregnancy).
ata extraction
Data about publication (First author’s last name, year of publi-
ation), country, number of cases with GDM and normal pregnant
omen (NPW), gestational ages at the time of evaluation, and
ean± standard deviation (SD) of serum Se concentration in both
DM and NPW groups were collected. Means and SDs were repre-
ented inmicrogramper litter (g/L) for all studies except for study
f Bo et al. [13] inwhich the datawere reported asmol/L.We tried
o convert all measurements in the study of BO et al. [13] to g/L,
ut the results were incomparable; therefore, we decided to use
he intact mentioned values. Two authors separately extracted the
ata (TJ and AAF) and discrepancies were resolved by debate with
third author (ASA).
tatistical methods
Mean serum selenium levels and its standard deviation (SD)
or participants in GDM and NPW was used to calculate the bias
orrected standardized mean difference (Hedges’ g) [17] which
as considered as effect size. Summary Hedges’ g with its cor-
esponding 95% conﬁdence interval (CI) was derived by using
andom effects model [18], which takes between-study variation
nto account. Subgroup analysis was performed to check for possi-
le sources of heterogeneity and between subgroup heterogeneity.
ata, effect estimates, and results of the meta-analyses were illus-
rated as forest plots. The forest plot displays effect estimates and
onﬁdence intervals for both individual studies andmeta-analysis.
ach study is represented by a block at the point estimate of inter-
ention effect with a horizontal line extending either side of the
lock [19].
To assess whether the observed differences in results is by
hance, Cochrane Q test (which is a chi-squared test) was used;
nd P<0.05 provides evidence of heterogeneity among the studies
219,20]. The degree of heterogeneity was quantiﬁed using I index:
2 =
[
(Q − df )
Q
]
× 100Q is the chi-squared statistic and df is its degrees of freedom. I2
values range between 0 and 100%, and I2 values of 25, 50 and 75%
are referred to as low, moderate, and high estimates, respectively
[20].
Sensitivity analysiswas also used to explore the extent towhich
the overall effects depend on a particular study or group of pub-
lications. Publication bias was assessed by visual inspection of
Begg’s funnel plots, which are simple scatter plots of the interven-
tion effect estimates from individual studies against somemeasure
of each study’s size or precision [21]. Formal statistical assess-
ment of funnel plot asymmetry was also incorporated with Egger’s
regressionasymmetry test andBegg’s adjusted rankcorrelation test
[22]. Stratiﬁed meta-analysis was used to assess the association
between serum Se concentration and gestational diabetes mellitus
in different gestational ages. In stratiﬁedmeta-analysis, studies are
classiﬁes on the basis of a moderator variable; then the effect size
is compared within each subgroup, separately [19,20]. Statistical
analyses were carried out by the use of Stata software version 11.2
(Stata Corp, College Station, TX, USA). P values less than 0.05 were
considered as statistically signiﬁcant.
Results
We found 1092 studies through our systematic search. We
excluded 620 studies with irrelevant topics, and also 368 articles
in animal models. From the 104 remained articles, 97 studies were
excludedbecause those studieshadevaluatedmaternal-fetal status
of several trace elements other than Se. Among the 7 related stud-
ies, one study had evaluated changes in serum Se concentration
during the gestational period in glucose-intolerant subjects [23],
thereby it was mentioned in systematic review but not in meta-
analysis. Finally, we found 6 articles to conduct the meta-analysis.
Fig. 1 shows the process.
Essential characteristics of studies enrolled inmeta-analysis are
shown in Table 1. In summary, from 723 pregnant women≥18
years participated in 7 studies, 701 subjects had been involved in
5 case control studies [11–13,15,16] and one cross-sectional study
[14]. In one study, 22 pregnant women had been followed during
their gestational period to evaluate the relation between gesta-
tional age and serum Se concentration [23]. Al-Saleh et al. [16] had
evaluated only obese pregnant women (BMI>30kg/m2); however,
in the other studies participants had been distributed from normal
to overweight or even obese. Measurement of serum Se concen-
tration had been performed at the time of delivery in 2 studies
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NOTE: Weights are from random effects analysis
Overall (I-squared = 94.0%, p = 0.000)
Molnar et al. (2008)
Al-Saleh et al. (2004)
Al-Saleh et al. (2007)
ID
Bo et al. (2005)
Tan et al. (2001)
Study
Kilinc et al. (2008)
-1.34 (-2.32, -0.36)
1.11 (0.41, 1.81)
-0.73 (-1.62, 0.16)
SMD (95% CI)
-0.66 (-1.02, -0.30)
-1.66 (-2.12, -1.21)
100.00
17.74
16.80
Weight
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%
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12,16] while in 3 studies it had been performed during 24–28 or
0 weeks of pregnancy when oral glucose tolerance tests (OGTTs)
ere done routinely [13–15]. Tan et al. assessed the Se concentra-
ion in 2 periods; ﬁrst, during 20–33weeks and second, between 33
nd 42 weeks of gestational period [11]. In the study conducted by
awkes et al. participants were checked between 12 and 34 weeks
f pregnancy [23].
ssessment of Se status
Selenium had been measured by graphite furnace atomic
bsorption spectrophotometry in 4 studies [12–14,16] while Tan
t al. andMolnar et al. used hydride generation atomic ﬂuorescence
pectrometry to report serum Se concentration [11,15]. In one
tudy, authors used high-performance liquid chromatographic-
uorescencemethod for determination of serum Se concentrations
23]. Four studies [12,14,16,23] stated that the used methods were
alidated, but the validation procedure and required data were not
emonstrated. Tan et al. [11] used the reference materials of cat-
le serum and human hair, while Molnar et al. [15] used a human
eference serum for methods validation; and only stated that the
ccuracy and precision of their methods were acceptable. Bo et al.
13] validated the used method by a normal human reference
erum. The authors did not demonstrate the results of validation
tudy; and only stated that the analytical procedures were reliable
nd the coefﬁcients of variation were 5.6–7.6%.ssessment of gestational diabetes mellitus
Almost all studies mentioned that the OGTTs had been per-
ormed on pregnant women according to standard criterionn serum Se concentration and GDM.
between 24 and 28 weeks of pregnancy. At ﬁrst a 50-g OGTT was
performed. If the 1-h postprandial serum glucose concentration
was greater than or equal to 140mg/dL, it was followed by a 3-
h 100-g OGTT. Blood samples were collected after 12h of fasting
and at 60, 120, and 180min after glucose ingestion. If two or more
of the following plasma values exceeded the mentioned values, it
was diagnosed as gestational hyperglycemia: 95mg/dL for fasting,
180mg/dL for 1-h, 155mg/dL for 2-h, and 140mg/dL for 3-h after
glucose ingestion [24]. Molnar et al. [15] used 75-g OGTT according
to World Health Organization Guidelines [25].
The association between serum Se concentration and GDM
The overall data from 6 studies (containing 147 women with
GDM and 360 normoglycemic pregnant women) demonstrated
that serum Se concentration is lower in women with gestational
hyperglycemia compared to normoglycemic pregnant women
(Fig. 2: Hedges =−1.34; 95% CI: −2.33 to −0.36; P<0.01). The chi-
squared test for heterogeneity was signiﬁcant (P≤0.001) and I2
was 94.0%. Considering Fig. 2, the inconsistencymight be due to the
studies ofAl-Saleh et al. andMolnar et al. [12,15]; but heterogeneity
still existed after excluding of mentioned studies in meta-analysis
(Fig. 3: P<0.01, and I2 =75.6%). The study teamdecided to conduct a
stratiﬁed meta-analysis according to gestational age at the time of
serum Se assessment. Three studies with 184 participants assessed
Se status in third trimester or at delivery [11,12,16], while 4 studies
with 417 participants had data on serum Se concentration in sec-
ond trimester [11,13–15]. Tanet al. assessed serumSe statusboth in
second and third trimesters [11]. Stratiﬁed meta-analysis showed
that concentration of Se in the sera of women with GDM was
lower than normal pregnant women both in second and third
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NOTE: Weights are from random effects analysis
Overall (I-squared = 75.6%, p = 0.006)
Bo et al. (2005)
Tan et al. (2001)
Kilinc et al. (2008)
Study
Al-Saleh et al. (2007)
ID
-1.08 (-1.57, -0.59)
-1.16 (-1.58, -0.73)
-0.66 (-1.02, -0.30)
-1.66 (-2.12, -1.21)
-0.73 (-1.62, 0.16)
SMD (95% CI)
100.00
27.61
29.34
26.79
%
16.25
Weight
-2.12 0 2.12
Fig. 3. Forest plot of the association between serum Se concentration and GDM after the extraction of 2 studies.
NOTE: Weights are from random effects analysis
.
Kilinc et al. (2008)
Tan et al. (2001)
ID
Study
Al-Saleh et al. (2007)
Molnar et al. (2008)
Bo et al. (2005)
Second trimester
Al-Saleh et al (2004)
Subtotal (I-squared = 93.2%, p = 0.000)
Tan et al. (2001)
Third trimester
Subtotal (I-squared = 95.0%, p = 0.000)
-1.66 (-2.12, -1.21)
-0.85 (-1.27, -0.43)
SMD (95% CI)
-0.73 (-1.62, 0.16)
1.11 (0.41, 1.81)
-1.16 (-1.58, -0.73)
-8.51 (-10.92, -6.09)
-0.68 (-1.60, 0.25)
-0.66 (-1.02, -0.30)
-2.81 (-5.21, -0.42)
16.03
16.16
Weight
%
13.90
14.93
16.14
6.47
63.26
16.37
36.74
0-10.9 10.9
Fig. 4. Forest plot of the association between serum Se concentration and GDM in each trimester.
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Overall (I-squared = 64.5%, p = 0.060)
ID
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rimesters, but the result was not signiﬁcant in second trimester
Fig. 4; second trimester: Hedges =−0.68; 95% CI: −1.60–0.25;
=0.15, third trimester: Hedges =−2.81; 95% CI: −5.21 to −0.42;
<0.05). The chi-squared test and I2 represented heterogeneity
mong the studies in each subgroup (Fig. 4; second trimester:
< 0.001 and I2 was 93.2%; third trimester: P<0.001 and I2 was
5.0%).
he association between serum Se concentration and impaired
lucose tolerance
Serum Se status had been compared in 3 studies containing
89 pregnant women with IGT and 314 normoglycemic pregnant
omen [11,13,14]. The overall data represented that serum Se sta-
us is lower among those with IGT (Fig. 5: Hedges =−0.85; 95% CI:
1.18 to−0.52). The chi-squared test and I2 denoted that therewas
eterogeneity among the studies (P=0.06, and I2 was 64.5%).
In spite of a brief asymmetry observed in Begg’s funnel plot, the
gger’s test demonstrated that there is no evidence of publication
ias (P=0.54).
iscussion
Several evidences indicate that serum selenium level decreases
uring pregnancy [26–28]. The probable reasons could be hemod-
lutional phenomenon in pregnancy, increased fetal requirement,
nd deposition in placenta [11,14,15]. In addition, due to increase
f lipid peroxidation during pregnancy, the activity of antioxidants
ike glutathione and erythrocyte glutathione peroxidase increases;
ence the level of serumSedecreases particularly in third trimester
3]. Women with GDM or IGT are more susceptible to oxidative
tress conditions due to hyperglycemic status and insulin resis-
ance. Therefore, the need for more Se is evident in such patients.
n the other hand, Se as an insulinomimetic element can have
eneﬁcial effects in GDM. Bo et al. [13] showed that serum Se con-
entration is negatively associated with gestational hyperglycemia
odds ratio =0.92, 95% CI: 0.87–0.95, P≤0.0001). Four of 6 studies
nrolled in ourmeta-analysis had conﬁrmed that serumSe concen-
ration is lower inwomenwithGDMcompared to normal pregnanten serum Se concentration and IGT.
women [11–14]. The result in one study was not signiﬁcant [16]
and Molnar et al. [15] reported inconsistent data. The overall data
demonstrated that serum Se concentration is signiﬁcantly lower
in pregnant women with gestational hyperglycemia comparing to
normal pregnant women (Fig. 2). Regarding the inverse correlation
between level of Se and obesity [14], the non-signiﬁcant result in
the study of Al-Saleh et al. [16] might be due to diversity in BMI
of cases and controls; the subjects were obese and BMI in cases
was signiﬁcantly lower thanBMI in control group (P≤0.05).Molnar
et al. stated that because of the lack of sufﬁcient data on plasma Se
concentration of GDM cases, it was not possible to reach a distinct
conclusion [15].
Stratiﬁed meta-analysis demonstrated that serum Se concen-
tration is lower in women with GDM both in second and third
trimesters; however the results were signiﬁcant after the 33th
week of pregnancy period. The reduction of Se levels at the end
of third trimester is more than the reduction in second trimester
(Fig. 4). This result must be due to higher tendency of insulin
resistance and also higher activity of peroxidase enzymes in third
trimester. Fig. 5 shows that serum Se concentration is lower in
women with IGT; this could be due to the effects of Se on glucose
tolerant mechanisms [13]. We found signiﬁcant negative correla-
tion between serum Se values and GDM prominent in the third
trimester. But we could not indicate a causal relationship between
Se and GDM due to the design of the studies (case–control or
cross sectional) enrolled in this meta-analysis. Moreover, it is
still unknown whether reduction in serum Se concentration is a
predisposing factor for GDM and IGT, or pregnant women with
hyperglycemic status have low serum Se levels. Cohort studies in
different populations are recommended to clarify the causality. The
other limitations of our study are as follows: (i) heterogeneity in
age, weight, and inﬂammatory status of the patients in studies,
which may affect serum Se concentration; and (ii) geographical
diversity of Se concentration in the soil that inﬂuences the dietary
Se intake among the populations and its unclear effect on serum Se
concentration. More precise investigations with the large popula-
tions are required to overcome the problems and reach to exact
conclusions about the role of Se supplementation in pregnant
women with GDM or IGT.
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